Ask AI
ProCE Banner Activity

Maximizing Safety and Efficacy of ADCs in Patients With HER2-Low or Ultralow mBC

Slideset

Download these slides from an ASCO 2025 live satellite symposium on HER2-low and HER2-ultralow mBC covering the key safety profile of antibody–drug conjugates, including guidelines and expert recommendations on how to manage adverse events with these agents.

Released: May 20, 2025

Expiration: November 19, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.